Pharma14 Adds New Zealand Medicine and Pricing Information

March 11, 2022

Pharma14 has announced that New Zealand is the latest country to be added to its list of over 66 countries in its drug pricing and medical data platform. The country relies on negotiations between drug makers and the Pharmaceutical Management Agency of New Zealand to establish prices. The island nation is a promising market for drug manufacturers, so understanding its pricing landscape is crucial for success in the region.

According to Pharma14, “Currently, the market in New Zealand is valued at a figure of around $985 million USD, with a large proportion of that figure being comprised of Rx products. There are also over 900 pharmacies in New Zealand that dispense over 50 million prescriptions per year, revealing New Zealand to be a fantastic country for manufactures of prescription drugs and products to establish new facilities there.”

To learn more and sign up for a live demo, click here.

(Source: Pharma14, March 8th, 2022)

Share This Story!